ENDEFR
Home › United States › ATLANTIC P3 LIFE SCIENCES HOLDINGS II, LLC

ATLANTIC P3 LIFE SCIENCES HOLDINGS II, LLC

Limited Liability Company · CAMDEN, United States · LEI 549300I8LEORP7EFR806
LEI activegroup parent

Summary

ATLANTIC P3 LIFE SCIENCES HOLDINGS II, LLC is registered in the United States. Its legal form is Limited Liability Company. ATLANTIC P3 LIFE SCIENCES HOLDINGS II, LLC is the ultimate parent of a group of 2 subsidiaries in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. It has 2 direct subsidiaries in GLEIF data. The LEI was first issued on 25 May 2018 and the record was last updated on 28 Sep 2026; the next renewal is due by 25 Oct 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formLimited Liability Company
Register · Register website
Registration number6884802
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O PARACORP INCORPORATED, 2140 S DUPONT HWY, 19934 CAMDEN, United States
Headquarters address4475 EXECUTIVE DRIVE, 92121 SAN DIEGO, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)14 May 2018
LEI549300I8LEORP7EFR806
LEI statusactive
LEI first issued25 May 2018
LEI record last updated28 Sep 2026
Next LEI renewal25 Oct 2027
Corroboration of the LEI recordfully corroborated

Group membership

ATLANTIC P3 LIFE SCIENCES HOLDINGS II, LLC this entity
BP3-SF4 1000 MARINA LLC United States
BP3-SF5 3000-3500 MARINA LLC United States
View the whole group: 2 subsidiaries in 1 countries

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
  • Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.

Direct subsidiaries (2)